Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 70121-1644
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 70121-1644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vial Label (Decitabine Amneal 02)
This is a description of a medication called Decitabine for Injection. It comes in a vial with 50mg of the medication. It is a cytotoxic agent and should only be used for intravenous infusion. The medication also contains monobasic potassium phosphate and sodium hydroxide, which are used for pH adjustment. The precautions, dosage information, and reconstitution details are included in the package insert or on the carton. It should be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
Carton Label (Decitabine Amneal 03)
This is a product label for Decitabine for Injection containing 50mg of Decitabine, manufactured in Malta and distributed by Amneal Pharmaceuticals LLC. The vials need to be stored at a temperature between 20°C to 25°C, and reconstituted with Sterile Water for Injection USP. The resultant solution will have a 5 mg per mL concentration, and it is a cytotoxic agent. Instructions are provided for reconstitution, dilution, stability, dosage, and storage with warnings to keep the drug take away from children, and to discard any unused portions after use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.